44 MILTON AVENUE, ALPHARETTA, GA
Amendment to Certificate of Incorporation Approved at Annual Meeting
Announces First Quarter 2026 Financial Results
Annual Report to Security Holders
Reports Fourth Quarter and Full Year 2025 Financial Results
Special Meeting Held; Matters Approved by Shareholders on March 11, 2026
CEO Letter to Shareholders: The Year in Review, The Year Ahead
Announces Financing of up to $26.8 Million to Progress Halneuron® Through Phase 2b Development
Dogwood Therapeutics Enters Equity Distribution Agreement for $8.56M
Q1
FY 2025
Q3
Q2
FY 2024
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Amended Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Correspondence
Submission Upload
Free Writing Prospectus